Export Import Growth Stories- Concord Biotech | Strategic Conversation with Ankur Vaid, CEO

Описание: The foundation of this success story was laid by Sudhir Vaid in 2000, with just 3 people on board. Ankur Vaid, was one of these three. In this strategic conversation with Raakesh Saraff, Ankur shares the core growth strategies behind the incredible growth- from 3 people to 1500, turnover of Rs 500 cr and a healthy EBIDTA of 50% (at the time of conversation in Jan 2021)

This success story, titled “Organic Growth”, is featured in the best-selling export import book- Plan or Perish, authored by Mr. Raakesh Saraff- MD, InfodriveIndia Pvt. Ltd.- the leading export-import market intelligence platform.

Buy Plan or Perish:
https://www.amazon.in/Plan-Perish-Raa...

Follow Mr. Raakesh Saraff on LinkedIn & Facebook:   / rakeshsarafinfodriveindia     / raakeshsaraff  
https://raakeshsaraff.com/
https://www.infodriveindia.com/

About Concord:

Concord Biotech Limited is a leading vertically integrated, R&D driven biotechnological powerhouse that manufactures Active Pharmaceutical Ingredients through fermentation & semi-synthetic process and finished formulations. It was founded in the year 2000 has transformed from a single-product company to a broad-spectrum solution provider, offering products across diversified therapeutic segments.

It is globally known for its products and has a commanding presence in more than 50 countries worldwide with efficient distribution infrastructure in markets like North America, Europe, Japan, Central & Latin America, Africa, Australia, New Zealand, Asia-Pacific as well as CIS and MENA countries, besides significant presence in India market. Concord is actively expanding its horizons by partnering with leading Global Pharmaceutical Companies by meeting their product development needs for API’s & Finished Formulations.

Source: http://www.concordbiotech.com/

Subscribe to our Channel
Connect with Us on LinkedIn:
  / infodrive-india